Loading
Latest filing published 19 Jan 2023 for Rakovina Therapeutics Inc. - formerly, Vincero Capital Corp., €7,016.
David Hyman discloses dealings in Rakovina Therapeutics Inc. - formerly, Vincero Capital Corp. to SEDI. We count 2 filings; the first trade dates from 18 October 2022 and the latest from 18 January 2023.
Purchases make up the whole of the open-market record (2 purchases, €14k). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. So far in 2023, the count stands at 1 purchase and no sales.
Most recently, on 19 January 2023, the filings show an open-market purchase worth €7,016 in Rakovina Therapeutics Inc. - formerly, Vincero Capital Corp. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations